Working… Menu

Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine(Hecolin®)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02189603
Recruitment Status : Completed
First Posted : July 14, 2014
Last Update Posted : August 17, 2018
Xiamen Innovax Biotech Co., Ltd
Xiamen Center for Disease Control and Prevention
Information provided by (Responsible Party):
Jun Zhang, Xiamen University